Two years ago, the World Health Organization (WHO) declared a public health emergency after a multi-country outbreak of mpox (formerly known as monkeypox). Now, in the summer of 2024, mpox is on the rise again. On August 14, The WHO declared a new public health emergency due to a recent outbreak in the Democratic Republic of the Congo (DRC) and other African countries.

Last month, the biopharmaceutical company Gilead shared groundbreaking results from a recent clinical trial (PURPOSE1) for long-acting injectable HIV prevention. The twice-yearly injectable drug, lenacapavir, provided total protection from HIV for a test group of 2,134 women in Uganda and South Africa. While lenacapavir has been used to treat multi-drug resistant HIV since 2022, this trial marks the first usage as pre-exposure prophylaxis (PrEP). PrEP is one tool to prevent the virus, and refers to anti-retroviral medication taken by people who do not have HIV to reduce the risk of contracting it through sexual transmission or injection drug use. These new findings offer immense promise for the future of PrEP as a global tactic to protect young women from contracting HIV. 

April 11 is the International Day for Maternal Health and Rights. Globally, 800 women die each day from preventable causes due to pregnancy and childbirth. Improving maternal health outcomes and preventing maternal deaths requires a human rights-based approach that protects a person’s right to survive childbirth, to access high-quality health care, to government accountability, to equity and non-discrimination when accessing care, and to family planning and contraception. Enshrining these rights for all pregnant people is key to meaningful progress towards the prevention of maternal deaths globally.

Today, March 8, is International Women’s Day (IWD). It is an annual occasion to celebrate the incredible achievements of women and girls globally, while acknowledging the work still needed to push forward to make the critical human rights issue of gender equality a reality.

The last two decades saw significant gains in reducing the incidence of malaria, but can we be doing even more to eradicate this disease? In early January 2024, a New York Times op-ed argued that millions were dying needlessly as tools to defeat malaria were within reach.

“The [COVID-19] pandemic, as all of you know, severely disrupted essential health services in countries around the world, and it left many health systems reeling from the drain on resources,” said Nidhi Bouri, Assistant Administrator for Global Health at the United States Agency for International Development (USAID) at a recent Wilson Center event to assess lessons learned in coping with the stressors created by the global health crisis.

“Women’s ability to access education, pursue a career outside the home, or participate politically often hinges on their ability to exercise control and autonomy over their own bodies and reproduction,” said Sarah Craven, Director of the North American Representation Office at UNFPA at a recent Wilson Center event, hosted in partnership with Population Institute, to launch their new report, Connecting the Dots: Sexual and Reproductive Health and Rights as Prerequisites for Global Gender Equity and Empowerment. 

The 2023 Women Deliver Conference in Kigali, Rwanda offered participants an opportunity to think deeply about gender equality, and the urgency of this moment in making progress was evident – even at a pre-conference event hosted by the United Nations Population Fund (UNFPA): Scaling Up Actions to End Preventable Maternal Deaths: Linkages with Family Planning, Bodily Autonomy and the Health Workforce.